Roberta Malaguarnera

4.0k total citations · 1 hit paper
72 papers, 3.2k citations indexed

About

Roberta Malaguarnera is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Roberta Malaguarnera has authored 72 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 35 papers in Endocrinology, Diabetes and Metabolism and 16 papers in Cancer Research. Recurrent topics in Roberta Malaguarnera's work include Metabolism, Diabetes, and Cancer (20 papers), Growth Hormone and Insulin-like Growth Factors (18 papers) and Cancer, Hypoxia, and Metabolism (11 papers). Roberta Malaguarnera is often cited by papers focused on Metabolism, Diabetes, and Cancer (20 papers), Growth Hormone and Insulin-like Growth Factors (18 papers) and Cancer, Hypoxia, and Metabolism (11 papers). Roberta Malaguarnera collaborates with scholars based in Italy, United States and United Kingdom. Roberta Malaguarnera's co-authors include Antonino Belfiore, Veronica Vella, Riccardo Vigneri, Francesco Frasca, Andrea Morrione, Marcello Maggiolini, Maria Luisa Nicolosi, Stefania Giuliano, Angela Mazza and Barbara Fruci and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Roberta Malaguarnera

66 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation

2025 16 citations Francesco Barbagallo, Daiana Ibarretxe et al. Cardiovascular Diabetology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roberta Malaguarnera Italy	32	1.6k	1.2k	792	686	440	72	3.2k
Veronica Vella Italy	31	1.4k 0.9×	1.2k 1.0×	677 0.9×	590 0.9×	148 0.3×	68	2.6k
Chongren Tang United States	32	1.3k 0.8×	830 0.7×	434 0.5×	497 0.7×	380 0.9×	58	3.2k
Anne T. Reutens Australia	26	1.5k 0.9×	688 0.6×	574 0.7×	222 0.3×	161 0.4×	38	2.9k
Liya Yin United States	32	1.4k 0.8×	452 0.4×	377 0.5×	427 0.6×	675 1.5×	73	2.9k
John Woods United States	28	1.7k 1.0×	846 0.7×	502 0.6×	236 0.3×	239 0.5×	41	3.5k
Theodoros Tsakiridis Canada	31	2.5k 1.6×	400 0.3×	575 0.7×	771 1.1×	286 0.7×	82	3.5k
Bonnie J. Deroo United States	20	1.9k 1.2×	1.2k 1.0×	964 1.2×	574 0.8×	146 0.3×	29	3.9k
Lionel Hebbard Australia	32	1.2k 0.8×	321 0.3×	489 0.6×	499 0.7×	1.1k 2.4×	51	2.7k
Gregory Michelotti United States	27	1.5k 0.9×	497 0.4×	253 0.3×	427 0.6×	1.5k 3.3×	48	3.2k
Jianxin Xie China	22	3.0k 1.8×	426 0.3×	358 0.5×	1.2k 1.8×	409 0.9×	40	4.1k

Countries citing papers authored by Roberta Malaguarnera

Since Specialization

Citations

This map shows the geographic impact of Roberta Malaguarnera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Malaguarnera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Malaguarnera more than expected).

Fields of papers citing papers by Roberta Malaguarnera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Malaguarnera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Malaguarnera. The network helps show where Roberta Malaguarnera may publish in the future.

Co-authorship network of co-authors of Roberta Malaguarnera

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Malaguarnera. A scholar is included among the top collaborators of Roberta Malaguarnera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Malaguarnera. Roberta Malaguarnera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barbagallo, Francesco, et al.. (2026). Assessment of N/L ratio and subclinical atherosclerosis in FH subjects with or without LDLR mutation. Journal of the Endocrine Society. 10(3). bvag001–bvag001.

Barbagallo, Francesco, Giovanni Pennisi, Antonio Gallo, et al.. (2025). Effect of inclisiran on lipid and mechanical vascular profiles in familial hypercholesterolemia subjects: results from a single lipid center real-world experience. Progress in Cardiovascular Diseases. 92. 108–117. 9 indexed citations

Torrisi, A., Mario Lentini, Salvatore Pezzino, et al.. (2025). The Promise and Challenges of 3D Bioprinting in Otolaryngology: A Contemporary Perspective Viewpoint. Clinical Otolaryngology. 50(5). 795–807.

Barbagallo, Francesco, Giovanni Pennisi, Ernestina Marianna De Francesco, et al.. (2025). Translating the effect of dual lipid reduction with PCSK9 inhibitors on a mechanical vascular instrumental biomarker in familial hypercholesterolemia subjects. Journal of Translational Medicine. 23(1). 1371–1371. 1 indexed citations

Briglia, Marilena, Roberta Malaguarnera, Gianpiero Tamburrini, et al.. (2025). Medulloblastoma: Molecular Targets and Innovative Theranostic Approaches. Pharmaceutics. 17(6). 736–736. 1 indexed citations

D’Esposito, Fabiana, F. Cappellani, Roberta Malaguarnera, et al.. (2025). Pericytes as Key Players in Retinal Diseases: A Comprehensive Narrative Review. Biology. 14(7). 736–736. 1 indexed citations

Malaguarnera, Roberta, et al.. (2025). Environmental plastic pollutants and endocrine-related cancer: An updated view. Ecotoxicology and Environmental Safety. 304. 119077–119077.

Barbagallo, Francesco, Daiana Ibarretxe, Ernestina Marianna De Francesco, et al.. (2025). Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation. Cardiovascular Diabetology. 24(1). 126–126. 16 indexed citations breakdown →

Maniaci, Antonino, Marilena Briglia, Giuseppe Montalbano, et al.. (2024). The Role of Pericytes in Inner Ear Disorders: A Comprehensive Review. Biology. 13(10). 802–802. 3 indexed citations

10.

Genovese, Carlo, A Garozzo, Floriana D’Angeli, et al.. (2022). Orobanche crenata Forssk. Extract Affects Human Breast Cancer Cell MCF-7 Survival and Viral Replication. Cells. 11(10). 1696–1696. 4 indexed citations

11.

Filippello, Agnese, Stefania Di Mauro, Alessandra Scamporrino, et al.. (2022). Molecular Effects of Chronic Exposure to Palmitate in Intestinal Organoids: A New Model to Study Obesity and Diabetes. International Journal of Molecular Sciences. 23(14). 7751–7751. 5 indexed citations

12.

Porcellati, Francesca, Stefania Di Mauro, Alessandra Scamporrino, et al.. (2021). Glucagon as a Therapeutic Approach to Severe Hypoglycemia: After 100 Years, Is It Still the Antidote of Insulin?. Biomolecules. 11(9). 1281–1281. 6 indexed citations

13.

Vella, Veronica, Alessandro La Ferlita, Michele Pellegrino, et al.. (2021). Novel Mechanisms of Tumor Promotion by the Insulin Receptor Isoform A in Triple-Negative Breast Cancer Cells. Cells. 10(11). 3145–3145. 17 indexed citations

14.

Filippello, Agnese, Stefania Di Mauro, Alessandra Scamporrino, et al.. (2021). High Glucose Exposure Impairs L-Cell Differentiation in Intestinal Organoids: Molecular Mechanisms and Clinical Implications. International Journal of Molecular Sciences. 22(13). 6660–6660. 28 indexed citations

15.

Belfiore, Antonino, Roberta Malaguarnera, Maria Luisa Nicolosi, et al.. (2018). A novel functional crosstalk between DDR1 and the IGF axis and its relevance for breast cancer. Cell Adhesion & Migration. 12(4). 1–10. 38 indexed citations

16.

Malaguarnera, Roberta, Veronica Vella, Maria Luisa Nicolosi, & Antonino Belfiore. (2017). Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer?. Frontiers in Endocrinology. 8. 314–314. 47 indexed citations

17.

Amaral, Ana Teresa, Cecilia Garofalo, Roberta Frapolli, et al.. (2015). Trabectedin Efficacy in Ewing Sarcoma Is Greatly Increased by Combination with Anti-IGF Signaling Agents. Clinical Cancer Research. 21(6). 1373–1382. 36 indexed citations

18.

Piro, Salvatore, Loriana Mascali, Francesca Urbano, et al.. (2014). Chronic Exposure to GLP-1 Increases GLP-1 Synthesis and Release in a Pancreatic Alpha Cell Line (α-TC1): Evidence of a Direct Effect of GLP-1 on Pancreatic Alpha Cells. PLoS ONE. 9(2). e90093–e90093. 26 indexed citations

19.

Malaguarnera, Roberta, Alaide Morcavallo, & Antonino Belfiore. (2012). The Insulin and IGF-I Pathway in Endocrine Glands Carcinogenesis. Journal of Oncology. 2012. 1–19. 26 indexed citations

20.

Franco, Aime T., Roberta Malaguarnera, Samuel Refetoff, et al.. (2011). Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice. Proceedings of the National Academy of Sciences. 108(4). 1615–1620. 177 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact